Shareholders Equity (Details) - Restricted Stock [Member] - $ / shares |
3 Months Ended | ||
|---|---|---|---|
Jun. 30, 2025 |
Mar. 31, 2025 |
Dec. 31, 2024 |
|
| Non-vested Restricted Stock Outstanding, Beginning Balance | 954,000 | 954,000 | 906,000 |
| Number of Shares, Granted | 48,000 | ||
| Non-vested Restricted Stock Outstanding, Ending Balance | 954 | 954 | 954,000 |
| Weighted Average Fair Value, Beginning Balance | $ 0.69 | $ 0.69 | $ 0.71 |
| Weighted Average Fair Value, Granted | 0.25 | ||
| Weighted Average Fair Value, Ending Balance | $ 0.69 | $ 0.69 | $ 0.69 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|